Fujifilm Medical Systems USA, Inc.
15
0
0
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
6.7%
1 terminated/withdrawn out of 15 trials
92.9%
+6.4% vs industry average
0%
0 trials in Phase 3/4
85%
11 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Acquisition and Clinical Image Evaluation of Fujifilm's High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images.
Role: lead
Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim
Role: collaborator
Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Fujifilm FFDM and DBT Reader Training Program
Role: lead
Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing
Role: lead
Pilot Mammography Reader Study to Assess Breast Cancer Detection in FFDM Plus DBT Versus FFDM Alone
Role: lead
Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
Role: lead
AI Colorectal Polyp Detection
Role: lead
A Multi-Reader Multi-Case Pivotal Trial
Role: lead
Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer
Role: lead
Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury
Role: lead
Study Comparing Blue Light Imaging (BLI) With Flexible Spectral-Imaging Color Enhancement (FICE)
Role: lead
Acquisition of Breast Mammography Images
Role: lead
Study Comparing Flexible Spectral-Imaging Color Enhancement (FICE) With Olympus Narrow Band Imaging (NBI)
Role: lead
Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital Mammography
Role: lead
Collection of FUJIFILM's 3Dimensional Mammograms
Role: lead
All 15 trials loaded